Compare Enveric Biosciences Inc (ENVB) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs IQIYI Inc - ADR — how do they compare? Enveric Biosciences Inc trades at $1.4 (market cap $5.32M), while IQIYI Inc - ADR trades at $1.25 (market cap $1.15B). The key difference: IQIYI Inc - ADR is far larger — about 216.2× Enveric Biosciences Inc's market cap, and IQIYI Inc - ADR is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | IQ | |
|---|---|---|
Market Cap | $5.32M | $1.15B |
Sector | Health | Media |
52-Week High | $17.40 | $2.79 |
52-Week Low | $1.28 | $0.96 |
Enterprise Value | $408.82K | $2.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
IQ stock trades at $1.235, up 6.47% today, with a bullish technical signal from moving averages despite overbought RSI readings. Revenue declined to $27.29B in 2025 with a net loss of $206.31M, though valuation ratios like P/S of 0.3 and P/B of 0.6 appear low. Recent news highlights AI initiatives and leadership changes, with analysts projecting potential rebounds despite earnings volatility.
The outlook is mixed: low valuations and AI growth opportunities offer upside, but persistent losses, revenue declines, and high debt pose significant risks. Analyst consensus leans buy (50%), but investors face headwinds from competitive pressures and macroeconomic uncertainty in China's streaming market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
